Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Nabi reports positive interim results from Nabi-StaphVAX pivotal trial

Aug. 27, 1999

Retrospective study supports safety of xenotransplantation

Aug. 25, 1999

Phase I study of Avant's vaccine delivery system shows promising results

Aug. 24, 1999

Dynavax completes patient enrollment and dosing in phase I ragweed allergy trial

Aug. 24, 1999

Xoma and Genentech expand hu1124 collaboration to include transplantation

Aug. 23, 1999

Known anti-HIV compound also shows potential in treating immune disorders

Aug. 20, 1999

SangStat's cold storage solution for donor hearts cleared by FDA

Aug. 19, 1999

New transplant agent marketed by Roche in U.K.

Aug. 18, 1999

Isotechnika advances development of new immunosuppressant

Aug. 17, 1999

Cangene receives notification of fast-track status for new anti-chickenpox product

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...